Rodman & Renshaw analyst Seema Sheoran initiated coverage of Enanta (ENTA) with a Buy rating and $20 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENTA:
- Enanta’s New RSV Trial in Infants: What Investors Should Watch in ENTA
- Enanta Shareholders Approve Board Elections and Equity Plan
- Enanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity
- Enanta files $150M mixed securities shelf
- Enanta reports Q1 EPS (42c), consensus (88c)